These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15802167)

  • 1. Antimicrobial treatment of community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Clin Chest Med; 2005 Mar; 26(1):65-73. PubMed ID: 15802167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines-concordant empiric antimicrobial therapy and mortality in patients with severe community-acquired pneumonia requiring mechanical ventilation.
    Sakamoto Y; Yamauchi Y; Yasunaga H; Takeshima H; Hasegawa W; Jo T; Matsui H; Fushimi K; Nagase T
    Respir Investig; 2017 Jan; 55(1):39-44. PubMed ID: 28012492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe community-acquired pneumonia in adults: current antimicrobial chemotherapy.
    Niven DJ; Laupland KB
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):69-81. PubMed ID: 19622058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy.
    Restrepo MI; Jorgensen JH; Mortensen EM; Anzueto A
    Curr Opin Infect Dis; 2001 Dec; 14(6):703-9. PubMed ID: 11964888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community acquired bacterial pneumonia.
    Anevlavis S; Bouros D
    Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-course antimicrobial therapy for community-acquired pneumonia.
    Kolditz M; Halank M; Höffken G
    Treat Respir Med; 2005; 4(4):231-9. PubMed ID: 16086597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial therapy of community-acquired pneumonia.
    File TM; Niederman MS
    Infect Dis Clin North Am; 2004 Dec; 18(4):993-1016, xi. PubMed ID: 15555836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empiric therapy of community-acquired pneumonia: guidelines for the perplexed?
    Cunha BA
    Chest; 2004 May; 125(5):1913-9. PubMed ID: 15136407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of new therapies for severe community-acquired pneumonia.
    Restrepo MI; Anzueto A
    Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia.
    Stahl JE; Barza M; DesJardin J; Martin R; Eckman MH
    Arch Intern Med; 1999 Nov; 159(21):2576-80. PubMed ID: 10573047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM; Restrepo MI; Anzueto A; Pugh J
    Crit Care; 2005 Dec; 10(1):R8. PubMed ID: 16420641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals.
    Dedier J; Singer DE; Chang Y; Moore M; Atlas SJ
    Arch Intern Med; 2001 Sep; 161(17):2099-104. PubMed ID: 11570938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community-acquired pneumonia: is it time to shorten the antibiotic treatment?
    Esposito S; Fiore M
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):933-8. PubMed ID: 18039078
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic stewardship in community-acquired pneumonia.
    Viasus D; Vecino-Moreno M; De La Hoz JM; Carratalà J
    Expert Rev Anti Infect Ther; 2017 Apr; 15(4):351-359. PubMed ID: 28002979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia.
    Zervos M; Mandell LA; Vrooman PS; Andrews CP; McIvor A; Abdulla RH; de Caprariis PJ; Knirsch CA; Amsden GW; Niederman MS; Lode H
    Treat Respir Med; 2004; 3(5):329-36. PubMed ID: 15606222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of Antibiotic Management of Community-Acquired Pneumonia.
    Bender MT; Niederman MS
    Semin Respir Crit Care Med; 2016 Dec; 37(6):905-912. PubMed ID: 27960214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term symptom recovery and health-related quality of life in patients with mild-to-moderate-severe community-acquired pneumonia.
    El Moussaoui R; Opmeer BC; de Borgie CA; Nieuwkerk P; Bossuyt PM; Speelman P; Prins JM
    Chest; 2006 Oct; 130(4):1165-72. PubMed ID: 17035452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
    Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A
    JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription of antibiotics for adults hospitalized with community-acquired pneumonia in Korea in 2004: a population-based descriptive study.
    Yoon YK; Kim EJ; Chun BC; Eom JS; Park DW; Sohn JW; Kim MJ
    Respirology; 2012 Jan; 17(1):172-9. PubMed ID: 21995414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.